These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18227822)

  • 1. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status.
    Waxman SG
    Nat Clin Pract Neurol; 2008 Mar; 4(3):159-69. PubMed ID: 18227822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
    Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channels as molecular targets in multiple sclerosis.
    Waxman SG
    J Rehabil Res Dev; 2002; 39(2):233-42. PubMed ID: 12051467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
    Waxman SG
    Nat Rev Neurosci; 2006 Dec; 7(12):932-41. PubMed ID: 17115075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Painful research: identification of a small-molecule inhibitor that selectively targets Nav1.8 sodium channels.
    Rush AM; Cummins TR
    Mol Interv; 2007 Aug; 7(4):192-5, 180. PubMed ID: 17827438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis.
    Waxman SG
    Trends Mol Med; 2006 May; 12(5):192-5. PubMed ID: 16574486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal protection in multiple sclerosis--a particular need during remyelination?
    Smith KJ
    Brain; 2006 Dec; 129(Pt 12):3147-9. PubMed ID: 17132643
    [No Abstract]   [Full Text] [Related]  

  • 8. A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis.
    Shields SD; Cheng X; Gasser A; Saab CY; Tyrrell L; Eastman EM; Iwata M; Zwinger PJ; Black JA; Dib-Hajj SD; Waxman SG
    Ann Neurol; 2012 Feb; 71(2):186-94. PubMed ID: 22367990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
    Cummins TR; Rush AM
    Expert Rev Neurother; 2007 Nov; 7(11):1597-612. PubMed ID: 17997706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigine.
    Kapoor R
    J Neurol Sci; 2008 Nov; 274(1-2):54-6. PubMed ID: 18486153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
    Khan O
    Neurology; 2007 May; 68(22 Suppl 3):S64-71; discussion S91-6. PubMed ID: 17548572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous neuroprotection in multiple sclerosis.
    Gonsette RE
    Acta Neurol Belg; 2010 Mar; 110(1):26-35. PubMed ID: 20514924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel blockers as neuroprotectants in neuroinflammatory disease: a double-edged sword.
    Stys PK
    Ann Neurol; 2007 Jul; 62(1):3-5. PubMed ID: 17661358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sodium channels and multiple sclerosis].
    Colotto M; Danese C
    Clin Ter; 2004 Jun; 155(6):245-8. PubMed ID: 15560285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na+ channel expression along axons in multiple sclerosis and its models.
    Waxman SG; Craner MJ; Black JA
    Trends Pharmacol Sci; 2004 Nov; 25(11):584-91. PubMed ID: 15491781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Loeb JA
    Neurology; 2007 May; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hitting a nerve: ion channels may hold the key for treating chronic pain.
    Shekhar C
    Chem Biol; 2009 Oct; 16(10):1022-3. PubMed ID: 19875073
    [No Abstract]   [Full Text] [Related]  

  • 19. Voltage-gated sodium channel gating modifiers: valuable targets for multiple sclerosis treatment.
    Mahdavi S; Gharibzadeh S; Ranjbar B; Javan M
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E17. PubMed ID: 21304115
    [No Abstract]   [Full Text] [Related]  

  • 20. Advancement of therapies for neuroprotection in multiple sclerosis.
    Lo A
    Expert Rev Neurother; 2008 Sep; 8(9):1355-66. PubMed ID: 18759548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.